Physician profile
Brian E Richardson
NPI 1861565624
$9,876.20
in general payments reported to CMS, 2019-2025
50 companies · $53.96 in 2025
The $53.96 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,281 · 2020: $653 · 2021: $1,431 · 2022: $2,319 · 2023: $2,302 · 2024: $1,837 · 2025: $53.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,158 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,158.11 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,282.60 | 2019-2024 | Xtandi |
| Dendreon Pharmaceuticals LLC | $1,147.36 | 2019-2024 | Provenge |
| Coloplast Corp | $927.69 | 2019-2024 | Speedicath, Titan |
| Sumitomo Pharma America, INC. | $773.80 | 2023-2024 | Gemtesa, Orgovyx |
| Axonics, INC. | $522.75 | 2020-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $492.73 | 2019-2024 | Akeega, Erleada |
| Antares Pharma, INC. | $455.69 | 2020-2023 | Tlando, Xyosted, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $402.24 | 2021-2024 | |
| Abbvie INC. | $400.08 | 2019-2023 | |
| Myriad Genetic Laboratories, INC. | $367.45 | 2021-2024 | Prolaris |
| Endo Pharmaceuticals INC. | $338.48 | 2019-2024 | Aveed, Xiaflex, Edex |
| Myovant Sciences INC. | $330.20 | 2021-2022 | |
| Boston Scientific Corporation | $299.68 | 2019-2024 | Lithovue |
| Urovant Sciences INC | $276.71 | 2021-2022 | |
| Pfizer INC. | $271.80 | 2020-2024 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.